Freenome and PCSC Merge in $1.1B Deal for Cancer Detection


Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Freenome and Perceptive Capital Solutions Corp Announce $1.1 Billion Business Combination to Advance Blood-Based Cancer Detection
Brisbane, CA, and New York - Freenome Holdings, Inc., an early cancer detection company, and Perceptive Capital Solutions Corp (Nasdaq: PCSC), a special purpose acquisition company (SPAC), have entered into a definitive business combination agreement. Upon closing, PCSC will redomicile as a Delaware corporation, be renamed Freenome, Inc., and its common stock is expected to be listed on Nasdaq under the ticker symbol "FRNM". The transaction is anticipated to be completed in the first half of 2026, creating a publicly listed company focused on transforming blood-based multi-cancer detection through an AI/ML-enabled multiomics platform.
... Read on — Members only
About Freenome Holdings, Inc.
More FRNM News
Health
Definitive Agreement

Daily overview of upcoming SPAC and IPO events – from initial announcement to definitive agreement and public listing.

Discover last week’s SPAC and IPO highlights, key trends, and market updates. Stay informed with SpacStar.
























